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SINTESIS DAN PENCIRIAN NANOPARTIKEL PERAK MENGGUNAKAN 
EKSTRAK AKUES POKOK Vernonia cinerea DAN AKTIVITI SITOTOKSIK 
MELAWAN SEL KASUMI-1  
 
ABSTRAK 
 
Nanoteknologi telah mendapat perhatian kerana semakin banyak digunakan dalam 
beberapa aplikasi seperti diagnosis dan rawatan kanser. Biosintesis nanopartikel 
perak (AgNPs) menggunakan ekstrak tumbuhan adalah lebih selamat dan jimat kos 
berbanding teknik kimia dan fizik. Kajian ini menghasilkan AgNPs dengan 
menggunakan nisbah berbeza iaitu 1:5, 1:10 dan 1:20 di antara ekstrak V. cinerea 
penyelesaian ekstrak dan perak nitrat. Campuran kedua-dua bahan ini telah 
diinkubasi di dalam air bersuhu 40 ˚C selama 24 jam. Pembentukan AgNPs telah 
dipantau untuk perubahan warna dan sifat AgNPs telah ditentukan menggunakan 
UV-Vis spektroskopi diikuti oleh mikroskop elektron penghantaran (TEM) dan 
analisis potensi zeta. UV-Vis spectra AgNPs telah menunjukkan maksima 
penyerapan pada 450 nm manakala gambar TEM menunjukkan bentuk AgNPs 
adalah bulat dengan purata saiz 15.29 nm. Nilai zeta V. cinerea-AgNPs ialah – 29.50 
mV dengan kawasan puncak intensity 100 %. Keputusan ini menunjukkan bahawa V. 
cinerea-AgNPs adalah agak stabil. Seterusnya, aktiviti proliferatif V. cinerea-AgNPs 
secara in vitro telah dikira menggunakan MTS assay. Nilai-nilai IC50 V. cinerea-
AgNPs terhadap sel Kasumi-1 adalah 24.42 μg/mL, 25.39 μg/mL dan 21.49 μg/mL 
masing- masing pada 24, 48 and 72 jam inkubasi. Sebaliknya, nilai IC50 ekstrak V. 
cinerea terhadap sel Kasumi-1 adalah 210.53 μg/mL dan 131.58 μg/mL pada 48 dan 
72 jam tetapi tiada kesan sel Kasumi-1 dilihat pada 24 jam inkubasi. Kesimpulannya, 
hasil kajian menunjukkan bahawa V. cinerea-AgNPs mempunyai potensi untuk 
menghasilkan AgNPs dan boleh digunakan sebagai agen anti-kanser terutama pada 
sel Kasumi-1. 
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SYNTHESIS AND CHARACTERISATION OF SILVER NANOPARTICLES 
USING Vernonia cinerea AQUEOUS EXTRACT AND THEIR CYTOTOXIC 
ACTIVITY AGAINST KASUMI-1 CELL LINES 
 
ABSTRACT 
 
 
Nanotechnology has gained attention due to their wide applications in various areas 
such as cancer diagnosis and therapy. Production of silver nanoparticles (AgNPs) 
using plant extracts is safer and cost-effective compared to chemical and physical 
methods. In this study, AgNPs were produced using 1:5, 1:10 and 1:20 ratios of 
Vernonia cinerea (V. cinerea) aqueous extract and silver nitrate solution. The 
mixtures were incubated for 24 hour at 40 ˚C water baths. The formation of silver 
nanoparticles was monitored for colour changes and characterized by UV-Vis 
spectroscopy followed by transmission electron microscopy (TEM) and zeta 
potential analyses. The UV-Vis spectrum of AgNPs showed absorption maxima at 
450 nm while TEM images showed that the shape of AgNPs is spherical in shape 
with an average size of 15.29 nm. The zeta value of synthesised V. cinerea-AgNPs is 
– 29.50 mV with a peak area of 100 % intensity. This indicates that the V. cinerea-
AgNPs are fairly stable. The cytotoxicity activity was tested in vitro against Kasumi-
1 cell line where the proliferative activity of V. cinerea-AgNPs was measured using 
MTS assay. The IC50 values of V. cinerea-AgNPs on Kasumi-1 cells were 24.42 
μg/mL, 25.39 μg/mL and 21.49 μg/mL at 24, 48 and 72 hours of incubations. On the 
other hand, the IC50 values of V. cinerea aqueous extract on Kasumi-1 cells were 
210.53 μg/mL and 131.58 μg/mL at 48 and 72 hours respectively but no significant 
difference on the Kasumi-1 cells at 24 hours incubation. Therefore, it is concluded 
that V. cinerea extract has potential in producing AgNPs extracellularly and used as 
anticancer agents particularly on Kasumi-1 cells.  
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CHAPTER 1 
INTRODUCTION 
 
 
 
1.1       Research Background                                                                         
Nanooncology has been a new breakthrough in the field of research because of its potential 
in the diagnosis and treatment of cancer (Jacob et al., 2012; Sahayaraj et al., 2014).  
Nanoscale treatment is preferable than chemotherapeutic drugs because of its high 
specificity, long shelf life, limited dose requirement, and stability (Chen et al., 2014; 
Riggio et al., 2011).  Metallic nanoparticles such as gold, platinum and silver are 
extensively used in nanomedicine as in targeted drug delivery systems, invasive imaging 
techniques and also in the development of engineered organs (Barkalina et al., 2014). 
Nanoparticles are preferred because of their capability to interact strongly with functional 
biomolecules and flow easily through cellular barriers. This is all due to their size, 
solubility, large surface area per volume ratio, and bioavailabilty (Gnanasekar et al., 2014). 
 Silver is the main particle of interest among other nanoparticles because of its 
medicinal values and anticancer ability (Mollick et al., 2015). Silver nanoparticles (AgNPs) 
have been applied in pharmaceutical and biomedical fields as an antimicrobial, cytotoxic, 
antioxidant and antibacterial agents towards many different types of bacteria such as 
Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus (Sahayaraj et al., 
2014). Due to their proven antibacterial properties, AgNPs have been widely applied in 
medical products like catheters, dental fillers, wound dressing and other medical devices 
(Sangiliyandi et al., 2013b). Unfortunately, the potential of AgNPs as anticancer agent is 
still new and yet to be discovered. 
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 Production of AgNPs can be achieved through different methods such as chemical 
and physical methods. However, these methods involve the use of toxic and hazardous 
chemicals such as sodium borohydride, potassium bitartrate, methoxypolyethylene glycol 
and hydrazine in their synthesis protocol which will potentially give impact on human 
health (Sukumaran & Eldho, 2012). According to Durai et al. (2014), sodium borohydride 
is not environmental friendly and expensive. Long term exposure towards sodium 
borohydride could give effects on the nervous system and lead to difficulty in breathing. 
Hence, biological methods for AgNPs synthesis using plant, fungi or bacteria have been 
suggested as one of eco-friendly alternative as compared to chemical synthetic procedures 
and physical methods (Satyavani et al., 2012). Among these methods, plant-synthesised 
AgNPs have been shown to be faster in production of AgNPs as compared to microbial 
synthesis method (Rajan et al., 2015). Besides that, this method is less toxic, low cost as 
well as environmentally friendly (Aruna et al., 2014). 
 Previous study done by Khay et al. (2012) has shown that that V. cinerea aqueous 
extract has a significant inhibitory effect on HT29 (colon adenocarcinoma) and HepG2 
(hepatoma) cancer cell lines. Leukaemia is known to be the seventh most prevalent cancer 
among adult age and it is also common among children (Meng et al., 2013). National 
Cancer Registry (NCR) of Malaysia reported that in 2007, 4.1 % from 741 cancer cases are 
leukaemia where 490 cases which is 66.1 % were among patients of 50 years and above 
while the rest 251 cases which is 33.9 % were among children aged of 0-14 years old 
(Zainal & Nor Saleha, 2011). However, there is no report the efficacy of V. cinerea 
aqueous extracts or V. cinerea-AgNPs on Kasumi-1 (human acute myeloid leukaemia) cell 
line in vitro. Hence, there is emerging need to develop therapeutic drugs that are 
biocompatible and effective by seeing the several of limitations and severe side effects of 
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current anticancer drugs. Thus, this study is initiated to investigate the anticancer effects of 
V. cinerea-AgNPs on Kasumi-1 cancer cell lines.  
 
 
 1.2       Research Objectives 
This study embarks on the following objectives:  
i. To synthesis and characterise the V. cinerea-AgNPs synthesised by V. cinerea 
aqueous extract.  
ii. To evaluate the effects of V. cinerea-AgNPs on the proliferation of Kasumi-1 cells. 
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CHAPTER 2 
LITERATURE REVIEW 
 
 
 
2.1 Nanotechnology 
 Nanotechnology is a vast developing field of nanoscience which is expected to be 
the latest advancement of technology in recent years. The term nanotechnology can be 
defined as the creation, exploitation and synthesis of materials for at least one dimension of 
smaller than 100 nanometers (Gholami-Shabani et al., 2014). Nanobiotechnology is a field 
resulting from the application of nanotechnology in the field of life science technology or 
biotechnology. Nanobiomedicine is one of the applications of nanobiotechnology that 
specially relates with fundamental studies in biology as well as its application to the fields 
of medicine (Jayachandra et al., 2014). 
 Nanooncology is an important area of nanomedicine and it is related to diagnosis 
and treatment of cancer. The example of nanooncology applications includes nanoparticles 
conjugated with monoclonal antibody for detection of cancer and quantum dots to diagnose 
cancer (Jain, 2010). A nanomaterial has large surface area to volume ratio due to their tiny 
size and that enables the material to pass through cellular barriers while carrying 
conjugated compounds such as nucleic acids, antibodies, drugs, probes and proteins 
(Thakor & Gambhir, 2013). 
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2.2 Silver Nanoparticles (AgNPs) 
2.2.1 Introduction to AgNPs 
 Silver metal is classified as an inert inorganic metal element that exists naturally 
and the products from ionisation of silver metal are silver ions (Barillo & Marx, 2014). In 
recent years, development of nanotechnology has allowed the production of silver metal ion 
into nanoscale particles with sizes less than 100 nm (Muthu et al., 2010). Catalytic activity, 
good electrical conductivity and high antibacterial activity are among the unique properties 
that make AgNPs has potential applications as therapeutic agents (Aruna et al., 2014). The 
nanoscale size of nanoparticles allows them to be chemically active results in the 
production of reactive oxygen species (ROS) and free radicals leading to inflammation and 
damage to the cells. Various studies have shown that AgNPs are able to penetrate sarcoma 
cells, primary neural cells and carcinoma cells and causing oxidative stress and damage to 
the genetic materials and induce the production of ROS.  
 AgNPs in vitro anticancer activities has been recorded that they interfere with the 
proliferation of several cancer cell lines. This include cervical carcinoma cell lines 
(Karunamoorthy et al., 2014; Panchanathan et al., 2013), human lung carcinoma A549 cell 
lines (Balaji et al., 2014; Renu et al., 2013), MCF-7 cell lines (Gnanasekar et al., 2014; 
Khatiravan et al., 2014), Dalton’s ascites lymphoma (DAL) cell lines (Muthu et al., 2010) 
and human glioblastoma cell lines (Rajan et al., 2015). 
 
2.2.2 Synthesis of AgNPs 
 The AgNPs can be synthesised by various methods such as chemical and physical 
methods (Ahmed et al., 2015). However, these methods are relatively expensive and 
require high energy and pressures for the synthesis of nanoparticles (Rajan et al., 2015). 
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Chemical method is the most commonly applied method for the synthesis of AgNPs using 
aqueous solution or organic solvents (Kholoud et al., 2010). A large amount of 
nanoparticles can be produced using chemical in a short period of time (Iravani et al., 
2014). However, this procedure requires the use of chemicals that are toxic and produced 
the non-environmentally friendly by-products (Sahayaraj et al., 2014).  
 In recent years, biological methods using bacteria, fungi, yeast or plant extracts 
have been implemented to synthesis AgNPs (Silambarasan & Abraham, 2013). Many 
research works employed plant leaves extract such as Ficus benghalensis (Saxena et al., 
2012), Rosa rugosa (Dubey et al., 2010), Stevia rebaudiana (Yilmaz et al., 2011), 
Chenopodium album (Dwidevi & Gopal, 2010), Nicotiana tobaccum (Prasad et al., 2010) 
to produce AgNPs. The production of AgNPs using plant aqueous extracts is preferable 
because plants are easily available, safe to handle and have many active compounds which 
potentially act as reducing agent and capping agent.  In addition, the cost of culture media 
and microorganism isolation can be minimised with the use of plant extracts (Prasad, 2014; 
Sahayaraj et al., 2014). 
  
2.3       Vernonia cinerea 
2.3.1 Introduction to V. cinerea 
 Vernonia is the largest genus in Vernonieae tribe which has about 1000 species of 
shrubs. It belonged to the family of Asteraceae. The genus was named after an English 
Botanist, William Vernon in late 1600 (Toyang & Verpoorte, 2013). The species are widely 
distributed in Africa, Europe and Asia (Old World) and North and South America (New 
World) but mostly are found in tropical and subtropical regions (Sangeeta & 
Venkatarathinakumar, 2011). This genus is edible and there are several species that have 
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been used for food, medicine and industries purposes. For example, folk used Vernonia 
species such as Vernonia amygdalina and Vernonia cinerea are used for treating diseases. 
However, there is still lack of studies on Vernonia cinerea species compared to Vernonia 
amygdalina. 
 
 
Figure 2.1: Vernonia cinerea plant collected from Pokok Sena, Kedah. The flowers (I), 
root (II) and leaves (III) of V. cinerea are shown in the above figure.                                                                                        
 
 
 The V. cinerea as shown in Figure 2.1 is an erect annual, branched and slender-
stemmed herb (Shelar et al., 2014). This plant is normally called as “little ironweed” in 
English, “joanbeer”, “kukshim” in Bengali, “puvamkurunnel” in Malayalam and 
“sahadevi” in Sanskrit and Hindi. This species can be found mainly in Asian countries such 
as India, Bangladesh, Sri Lanka and Malay island (Abirami & Rajendran, 2012). Its natural 
habitat is at the roadside, open waste places and dry grassy areas (Md. Ahsanul et al., 
2012). It can grow up to 12 – 75 cm high (Shelar et al., 2014). The stems are cylindrical 
solid hairy and basal region of branches greenish-brown (Md. Ahsanul et al., 2012). The 
leaves are dark-green alternate spiral or elliptic with characteristics odour and has bitter 
(I) (II) (III) 
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taste. The flowers are white, pink, violet reddish or purple in rounded or flat-topped 
corymbs (Shelar et al., 2014). 
 
2.3.2 Ethno-medicinal uses of V. cinerea 
 V. cinerea is tropically used as traditional herbal medicine in the area where it is 
historically grown like grassy areas of Southest Asia and Hawaii (Sahayaraj et al., 2014). 
All parts of the V. cinerea including roots, leaves and flowers have their own therapeutic 
values. The whole plants have been recognized in the Ayurvedas (Asha & Abraham, 2015) 
and use for treatments of intermittent fever, filariasis, blisters, boils and vaginal discharges 
in Indian Ayurvedic medicine (Arivoli et al., 2011). In traditional Chinese herbal system, 
the whole plant has been used as a tranquilliser and sedative and for the treatment of fever, 
cold, sore throat, headache, eczema, mastitis, bleeding, swelling, dysentery, dyspepsia, pus, 
infection and injuries (Chen et al., 2006; Hsu et al., 2011; Lai & Wu, 2013). 
 It is also reported that the plant can be used to treat cancer and various 
gastrointestinal disorders (Choudhary et al., 2013)  Abirami and Rajendran (2012) has 
reported that in traditional medicine, the practitioners use the plant as smoking cessation 
and relief of asthma, cough, fever, malaria, urinary calculi and arthritis. The whole plant is 
traditionally combined with small dose of quinine to treat malaria fevers (Asha & 
Abraham, 2015). The plant also provides remedy for diarrhoea, stomach ache, cough and 
bronchitis in the decoction form (Rajamurugan et al., 2011).  
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2.3.3 Anticancer activities of V. cinerea 
 V. cinerea have been documented contain phytochemicals flavonoid and 
sesquiterpene lactones that have important effects on cancer activity. (Patel et al., 2010; 
Toyang & Verpoorte, 2013). According to Pratheeshkumar and Kuttan (2011), Vernolide-A 
sesquiterpene lactones present in V. cinerea is responsible for cytotoxicity and 
antimetastatic activity towards cancer cells. It has been reported that there are presence of 
apoptotic bodies, cytoplasmic shrinkage and nuclear condensation when B16F-10 
melanoma cells were treated with vernolide-A (Pratheeshkumar & Kuttan, 2011). 
According to Chadwick et al. (2013), sesquiterpene lactones can inhibit over-expression of 
NF-KB that is usually found in various cancers. The sesquiterpene lactones from V. cinerea 
extract play significant role in regulating inflammatory response and act as an anticancer 
against various cell types such as colon adenocarcinoma, lung large carcinoma and Hela 
tumor cell lines (Latha et al., 2010; Pratheeshkumar & Kuttan, 2011). 
 
2.4 Acute Myeloid Leukemia 
 Acute myeloid leukemia (AML) is cancer of myeloid blood cells and is 
characterised by accumulation of immature myeloid progenitors in the bone marrow and 
peripheral blood (Chen et al., 2014). There are several chromosomal translocations present 
in AML and the most common chromosomal abnormalities is t (8; 21) (q22; q22). The t (8; 
21) (q22; q22) translocation resulted from the fusion of the AML1 gene on chromosome 21 
with ETO gene on chromosome 8 (Jiang et al., 2013).  
 In recent years, cytosine arabinoside (Ara-C) based chemotherapy is one of the 
common treatment options for AML patients (Chen et al., 2014). Since Ara-C has several 
undesirable side effects, this nucleoside analog cannot be given to patients in high dosage. 
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Moreover, high dosage chemotherapy is also not suitable for elder patients. Thus, it is very 
important to develop alternative therapy for the purpose of combating cancer by targeting 
the genetic aberration of leukemia cells. Plants may provide rich resources for cancer 
treatment. V. cinerea is one of the plant that have been shown to contain active compounds 
capable of inhibiting the growth of breast cancer (Yuan et al., 2014), However, no research 
has been done to investigate the effect of V. cinerea on the growth of leukemia cancer cells.  
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CHAPTER 3 
MATERIALS AND METHODS 
 
 
 
3.1 Materials 
Before use in this study, all glasswares were sterilized and autoclaved for 1 hr at 121 ˚C at a 
pressure of 100 kPa. 
 
3.2 Methods 
3.2.1 Preparation of V. cinerea aqueous extract     
The whole plant of V. cinerea was collected from Pokok Sena, Kedah. The whole plant was 
washed few times using tab water to remove dirt, rinse with distilled water before cut into 
small pieces. Then, the samples were dried in an oven (Daihan Labtech, Korea) at 40 ˚C for 
overnight. After that, the dried samples were grounded into coarse powder using blender 
and the powder was stored in the Schott bottles at – 20 ˚C until used. 
 The aqueous extract was prepared by mixing 40 g of coarse powder with 600 mL 
distilled water in 1000 mL glass beaker. The mixture was boiled for 30 min until the colour 
of the aqueous solution change from light yellowish to dark green. The extracts were 
cooled down at room temperature and centrifuged at 2000 rpm (Heraeus multifuge 3SR+ 
centrifuge, Thermo Scientific) for 15 min at 25 ˚C to separate supernatant and pellet. Then, 
the supernatant was collected and filtered using Whatmann filter paper No 1 (Sartorius, 
Germany) and stored at 4 °C in Schott bottles until further used. 
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Figure 3.1: Coarse powder (A) and a Aqueous extract (B) of whole plant of V. cinerea.  
 
3.2.2 Synthesis of V. cinerea-AgNPs 
The AgNPs were prepared by mixing V. cinerea aqueous extract with 1 mM silver nitrate 
(AgNO3) solution (Qrec, New Zealand). In this study, several incubation periods were 
selected at 0, 0.5, 1, 2, 4, 9 and 24 hr. The 5 mL of V. cinerea aqueous extract were added 
to AgNO3 solution at 25 mL, 50 mL and 100 mL to produce mixture with ratio of 1:5, 1:10 
and 1:20. The mixtures were incubated in a water bath at 40 ˚C for 24 hr until the colour of 
the solution turned from light yellow to dark brown.  
 
 
 
 
A B 
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3.2.3 Characterisation of the V. cinerea-AgNPs 
The V. cinerea-AgNPs synthesised at different ratios and incubation time were 
characterised by Ultraviolet-Visible (UV-Vis) Spectroscopy. Based on the UV-Vis 
Spectroscopy analysis, samples that are showing maximum absorption peak around 430 – 
450 nm were selected and further characterised by Transmission Electron Microscopic 
(TEM) Analysis and Zeta Potential Analyses. 
 
3.2.3.1 Ultraviolet-Visible (UV-Vis) Spectroscopy Analysis 
The formation of V. cinerea-AgNPs were monitored by observing the colour changes at 
0.5, 1, 2, 4, 9 and 24 hr and the samples were characterised by UV-Vis spectroscopy 
(Varian Cary 50 UV-Vis Spectrophotometer). The reduction of the silver ions in solution 
was monitored by measuring the absorbance values of 1 mL of V. cinerea-AgNPs solution 
at wavelength range between 200 – 550 nm. Distilled water was used as blank. Based on 
result obtained from UV-Vis, samples at 24 hr incubation time was selected for further 
characterisation. Before analysis, the solution was centrifuged at 6 000 rpm for 15 min. 
After that, the supernatant was discarded and the pellet was re-suspended with sterile 
distilled water before dried for 48 hr at 40 ˚C in the oven (Daihan Labtech, Korea).  
 
3.2.3.2 Transmission Electron Microscopic (TEM) Analysis 
TEM analysis was carried out to visualise the size and shape of synthesised V. cinerea-
AgNPs. The sample was sent to School of Biological Sciences, USM for analysis. Briefly, 
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the sample was suspended in 95 % alcohol followed by 15 min ultrasonication using 
ultrasonic water bath Elmasonic S 80H (Elma, Germany). Then, a small drop of suspension 
was placed on a “staining mat”. A carbon coated copper grid was inserted into the drop 
with the coated side grid placing upwards. The thin film suspensions on the grid were dried 
for 10 min and the grid was removed before screened in Transmission Electron Microscope 
(Zeiss Libra 120 Transmission Electron Microscope, USA).   
 
3.2.3.3 Zeta Potential Analysis 
The synthesised V. cinerea-AgNPs were sent to Analytical Lab, School of Chemical 
Engineering, USM for characterisation of colloidal stability in dispersion using Zetasizer 
Nano-ZS90 System (Malvern, UK). Stock solution at 0.1 mg/mL was prepared by mixing 
1.5 mg of V. cinerea-AgNPs powder with 15 mL distilled water. The suspension was 
placed in ultrasonic bath for 20 min. The suspension was then transferred into the 
measurement cell. The measurements were performed for three times for each sample. 
 
3.2.4 Cell Culture 
The AML cell line, Kasumi-1 cell line was a gift from Professor Norazah Mohd Yusof 
(USM RUI grant 1001CIPPT/812095). The cells were cultured in complete Roswell Park 
Memorial Institute-1640 (RPMI 1640) (GIBCO, USA) supplemented with sterile 10 % 
heat-inactivated fetal bovine serum (GIBCO, USA), 1% of 10 units/mL penicillin-
streptomycin (GIBCO, USA) and 1% of 200 mM-L-Glutamine Stock Solution (GIBCO, 
USA). To culture the cells, frozen cells from – 80 ˚C freezer were thawed immediately in a 
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water bath at 37 ˚C until the cells becomes semi-fluid. The semi-fluid cells suspension were 
diluted in pre-warmed complete RPMI-1640 growth medium (GIBCO, USA) and 
centrifuged at 1800 rpm for 7 min. The DMSO containing supernatant was then discarded 
and the pellet was re-suspended with pre-warmed complete RPMI-1640 growth medium 
before transferred into 25 cm2 tissue culture flask. The cells suspension was then incubated 
in the CO2 incubator (Thermo Scientific, USA) at 37 ˚C in 5 % CO2. The cells were 
routinely observed under inverted microscope (Carl Zeiss Axiovert 40 CFL, USA) and the 
culture medium was changed every 3 days. Cells were grown until it reached 70 to 80 % 
confluency before used for cell proliferation assay.  
 
3.2.5 Cell Proliferation Assay 
The cytotoxicity effect of V. cinerea aqueous extract and V. cinerea-AgNPs on Kasumi-1 
cell was determined using Cell Titer 96® AQueous Non-Radioactive Cell Proliferation 
Assay kit (Promega, USA) which composed of [3-(4, 5-dimethylthiazol-2-yl)-5-(3-
carbonxymethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium/phenazine methosulphate; 
MTS] and (phenazine methosulfate; PMS). The assay was performed according to 
manufacturer’s protocol. The Kasumi-1 cells at 70 % to 80 % confluency were plated at a 
density of 5 × 104 cells in each well of 96-well plate. Following that, the cells were treated 
with V. cinerea-AgNPs, V. cinerea aqueous extract and AgNO3 solution in a serial dilution 
manner at 1.96 μg/mL, 3.91 μg/mL, 7.82 μg/mL, 15.63 μg/mL, 31.25 μg/mL, 62.5 μg/mL, 
125 μg/mL, 250 μg/mL and 500 μg/mL. Untreated cells were used as negative control and 
camptothecin at 1.25 μg/mL was used as a positive control. Each treatment was performed 
in triplicate. The cells were incubated in 37 ˚C in a humidified 5 % CO2 incubator (Thermo 
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Scientific, USA) for 24, 48 and 72 hr. Following the incubation time interval, 20 μL of 
mixture of MTS/PMS solution were added to the cultured cells. The cells were then 
incubated for 3 hr at 37 ˚C in a humidified 5 % CO2 incubator. The plates were read at 490 
nm using an ELISA plate reader (Bio Tek, USA). The half maximal inhibitory 
concentration (IC50) which means the sample concentration that caused 50% cell death 
were determined from the graph.  
 
The cell viability (%) was calculated as follows: 
 
Percentage Cell Viability (%) =          Mean OD of treated cells            ×   100                     
                                                   Mean OD of untreated (control) cells 
 
Where, OD is the optical density. 
 
3.2.6 Statistical Analysis 
All statistical analyses were performed using Microsoft Excel 2010 and IBM SPSS 
Statistics 22.0 and expressed as means ± S.D. Treatment effects were determined using 
one-way ANOVA followed by Bonferroni post-hoc analysis. Values were considered as 
statistically significant if the p- value is less that 0.05 (p ˂ 0.05). 
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CHAPTER 4 
RESULTS 
 
 
 
4.1 Characterisation of Synthesised V. cinerea-AgNPs 
4.1.1 UV-Vis Spectroscopy Analysis  
 The formation of V. cinerea-AgNPs can be observed according to the colour 
changes of the mixture.  Figure 4.1 shows the colour changes observed in mixture of V. 
cinerea aqueous extract and AgNO3 at different ratios. For each incubation period, the 
AgNO3 solution at 25 mL, 50 mL and 100 mL were mixed with 5 mL of V. cinerea 
aqueous extract to produce mixture with ratio of 1:5, 1:10 and 1:20. Upon addition of V. 
cinerea aqueous extract to the AgNO3 solution, the solution changed from colourless to 
pale yellow. The solution changed to yellowish-brown within 1 hr at 1:20 ratio. In contrast, 
the solutions with ratio of 1:5 and 1:10 show no colour changes within 1 hr of incubation. 
At 24 hr of incubation, the solution with ratio of 1:20 turned to dark brown while mixture at 
ratio 1:5 and 1:10 showed light brown.  
 Figure 4.2 shows the UV-Vis spectra recorded from the V. cinerea aqueous extract 
reaction at different time intervals. The spectrum showed maximum absorption peak at 450 
nm for solution at 1:20 ratio (Figure 4.2 C). However, no distinction peaks were observed 
for the mixture at ratios of 1:5 and 1:10. 
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Figure 4.1: Synthesis of V. cinerea-AgNPs. The V. cinerea aqueous extract was added into 
AgNO3 solution at (a) 1:5 (b) 1:10 (c) 1:20 ratios. The colour of the mixture changes from 
pale yellow at 0 hr to dark brown at 24 hr. 
0.5 hr  0 hr  1 hr  
2 hr  4 hr  9 hr  24 hr  
Silver nitrate 
solution (1 mM) 
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Figure 4.2: UV–Visible spectra recorded for mixture of V. cinerea aqueous extract with aqueous silver nitrate at (A) ratio 1:5 (B) ratio 
1:10 (C) ratio 1:20 incubated at different time intervals. 
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4.1.2 TEM Analysis 
 The size and shape of V. cinerea-AgNPs were determined using TEM. Figure 
4.3 (A) and (B) shows the representative images of TEM analysis of V. cinerea-
AgNPs with most of the AgNPs were roughly circular in shape with smooth edge. 
The sizes of the particles range from 5.83 nm to 31.44 nm. Figure 4.3 (C) represents 
the frequency of TEM size distribution calculated by measuring over 50 particles in 
random fields of TEM view. The particle size ranges from more than 10 to 15 nm 
(>10 to 15 nm) was observed at the highest level with 37 % while the particles at 
more than 20 nm was observed at lowest level with 7 %.  The average diameter of 
AgNPs as observed by TEM was 15.29 ± 6.16 nm.  
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Figure 4.3: Representative images of TEM analysis of V. cinerea-AgNPs (A & B) with different particle size ranges from 5.83 nm to 
31.44 nm observed at different angles. (C) Frequency of size distribution of V. cinerea-AgNPs. 
A B C 
 22 
 
4.1.3 Zeta Potential Analysis 
 The stability of V. cinerea-AgNPs in solution was determined using zeta 
potential analysis by measuring electrical charges on the surface of V. cinerea-
AgNPs. As shown in Figure 4.4 and Table 4.1, the zeta potential value of V. cinerea-
AgNPs was – 29.50 mV with a peak area of 100% intensity.  
 
 
 
Figure 4.4: Zeta potential distribution of AgNPs synthesised from V. cinerea aqueous 
extract.  
 
Table 4.1: Zeta potential measurement of synthesised V. cinerea-AgNPs. 
 
Zeta potential – 29.50 mV 
Zeta deviation 4.07 mV 
Polarity  Negative  
Conductivity  0.0220 mS/cm 
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4.2 Proliferative effects of V. cinerea-AgNPs on Kasumi-1 cells  
 The IC50 values were 24.42 μg/mL, 25.39 μg/mL and 21.49 μg/mL at 24, 48 
and 72 hr of incubations, respectively as shown in Fig. 4.5. Figure 4.6 shows the 
effects of V. cinerea-AgNPs on the proliferation of Kasumi-1 cells. The V. cinerea-
AgNPs have significantly (p < 0.05) inhibited the proliferation of Kasumi-1 cells 
from the concentration of 31.25 μg/mL to 500 μg/mL at 48 and 72 hr of incubations 
as compared to untreated cells. On the other hand, at 24 hr of incubations, the growth 
inhibition was only observed significantly (p < 0.05) at concentration ranges from 
15.63 μg/mL to 250.00 μg/mL. The lowest percentage of cell viability following the 
treatment of V. cinerea-AgNPs was significantly (p < 0.05) observed with 
approximately 21 % at concentrations of 31.25 μg/mL. The data also revealed that 
there were no significant differences observed in cells treated with AgNO3 at 24 hr 
of incubations. Camptothecin was used as a positive control in this study and has 
significantly (p < 0.05) inhibited the cell proliferation at all incubations times. 
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Figure 4.5: Growth inhibitory effects of V. cinerea-AgNPs on Kasumi-1 cells. The lines represent the IC50 values that inhibit cell 
proliferation at 24 hr, 48 hr and 72 hr of incubation times. 
 
